ASP Isotopes Inc. Common Stock (ASPI) is a publicly traded company in the Basic Materials sector, operating within the Chemicals industry. The company is headquartered in Washington, FL, United States. The current CEO is Paul Elliot Mann.
ASPI has IPO date of 2022-11-10, 136 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $415.49M.
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
